当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析 - 现金流量表

拓新药业

(301089)

  

流通市值:21.37亿  总市值:30.17亿
流通股本:8964.93万   总股本:1.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金168,937,590.1781,824,745.02279,456,032.62229,605,482.71
  收到的税费返还2,308,056.11,099,914.556,329,215.115,815,039.31
  收到其他与经营活动有关的现金908,897.6755,531.6824,452,838.9510,321,516.6
  经营活动现金流入小计172,154,543.8783,680,191.25310,238,086.68245,742,038.62
  购买商品、接受劳务支付的现金81,102,126.6338,778,473.95121,589,748.24111,190,316.21
  支付给职工以及为职工支付的现金70,079,409.1235,849,925.96139,856,823.74106,136,972.94
  支付的各项税费7,143,774.373,994,937.7223,625,697.5217,027,745.36
  支付其他与经营活动有关的现金18,380,757.266,466,357.8451,352,718.2134,176,587.49
  经营活动现金流出小计176,706,067.3885,089,695.47336,424,987.71268,531,622
  经营活动产生的现金流量净额-4,551,523.51-1,409,504.22-26,186,901.03-22,789,583.38
二、投资活动产生的现金流量:
  收回投资收到的现金211,095,074.0375,347,366.39984,823,350.64725,000,000
  取得投资收益收到的现金--172,197.63,911,595.04
  投资活动现金流入小计211,095,074.0375,347,366.39984,995,548.24728,911,595.04
  购建固定资产、无形资产和其他长期资产支付的现金33,591,084.326,877,871.0244,454,904.4234,571,342.54
  投资支付的现金210,000,00060,000,000870,000,000670,000,000
  投资活动现金流出小计243,591,084.3266,877,871.02914,454,904.42704,571,342.54
  投资活动产生的现金流量净额-32,496,010.298,469,495.3770,540,643.8224,340,252.5
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金91,835.7351,785.414,167.01-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计91,835.7351,785.414,167.01-
  支付其他与筹资活动有关的现金--1,224,188.161,224,188.16
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--1,224,188.161,224,188.16
  筹资活动产生的现金流量净额91,835.7351,785.4-1,210,021.15-1,224,188.16
四、汇率变动对现金及现金等价物的影响-521,201.1-290,232-287,930.55-154,322.2
五、现金及现金等价物净增加额-37,476,899.176,821,544.5542,855,791.09172,158.76
  加:期初现金及现金等价物余额104,637,524.34104,637,524.3461,781,733.2561,781,733.25
  期末现金及现金等价物余额67,160,625.17111,459,068.89104,637,524.3461,953,892.01
补充资料:
  净利润-27,960,796.93--69,661,027.7-
  资产减值准备5,644,145.75-16,116,367.19-
  固定资产和投资性房地产折旧37,219,545.36-62,432,781.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧37,219,545.36-62,432,781.88-
  无形资产摊销1,420,166.1-2,881,512.27-
  长期待摊费用摊销483,309.06-876,477.19-
  固定资产报废损失19,805.06-416,386.26-
  公允价值变动损失-417,019.17--147,519.18-
  财务费用584,301.65-428,331.08-
  投资损失-947,554.85--4,119,715.12-
  递延所得税-806,850.37--3,684,929.54-
  其中:递延所得税资产减少-795,585.05--1,398,308.88-
    递延所得税负债增加-11,265.32--2,286,620.66-
  存货的减少-30,146,505.89--15,354,588.77-
  经营性应收项目的减少12,076,198.96--15,069,455.3-
  经营性应付项目的增加-837,370.61--14,447,074.37-
  现金的期末余额67,160,625.17-104,637,524.34-
  减:现金的期初余额104,637,524.34-61,781,733.25-
  现金及现金等价物的净增加额-37,476,899.17-42,855,791.09-
公告日期2026-08-282026-04-282026-03-282025-10-29
审计意见(境内)标准无保留意见
TOP↑